Anixa Biosciences Stock Analysis

Anixa Stock Analysis Notes

About 14.0% of the company shares are held by institutions such as insurance companies. The book value of Anixa Biosciences was presently reported as 0.78. The company recorded a loss per share of 0.34. Anixa Biosciences had not issued any dividends in recent years. The entity had 1:25 split on the 26th of June 2015. Anixa Biosciences, Inc., a biotechnology company, develops therapies and vaccines focusing on critical unmet needs in oncology and infectious diseases. Anixa Biosciences, Inc. was incorporated in 1982 and is based in San Jose, California. Anixa Biosciences operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 4 people. For more info on Anixa Biosciences please contact Amit Kumar at 408 708 9808 or go to https://www.anixa.com.

Anixa Biosciences Investment Alerts

Anixa Biosciences Upcoming and Recent Events

Anixa Largest EPS Surprises

View All Earnings Estimates

Anixa Stock Institutional Investors

Note, although Anixa Biosciences' institutional investors appear to be way more sophisticated than retail investors, it remains unclear if professional active investment managers can reliably enhance risk-adjusted returns by an amount that exceeds fees and expenses.

Anixa Market Capitalization

The company currently falls under 'Small-Cap' category with a current market capitalization of 101.12 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Anixa Biosciences's market, we take the total number of its shares issued and multiply it by Anixa Biosciences's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities.

Anixa Profitablity

Management Efficiency

Anixa Biosciences has return on total asset (ROA) of (0.2809) % which means that it has lost $0.2809 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (0.4302) %, meaning that it created substantial loss on money invested by shareholders. Anixa Biosciences' management efficiency ratios could be used to measure how well Anixa Biosciences manages its routine affairs as well as how well it operates its assets and liabilities. Return On Tangible Assets is likely to drop to -0.46 in 2024. Return On Capital Employed is likely to drop to -0.57 in 2024. At this time, Anixa Biosciences' Total Assets are fairly stable compared to the past year. Total Current Assets is likely to rise to about 30.6 M in 2024, whereas Non Current Assets Total are likely to drop slightly above 181.4 K in 2024.

Technical Drivers

As of the 15th of April 2024, Anixa Biosciences shows the Standard Deviation of 4.74, risk adjusted performance of (0.03), and Mean Deviation of 3.34. Anixa Biosciences technical analysis gives you the methodology to make use of historical prices and volume patterns to determine a pattern that approximates the direction of the firm's future prices. Put another way, you can use this information to find out if the firm will indeed mirror its model of historical prices and volume momentum, or the prices will eventually revert. We were able to collect and analyze data for thirteen technical drivers for Anixa Biosciences, which can be compared to its peers. Please confirm Anixa Biosciences coefficient of variation and value at risk to decide if Anixa Biosciences is priced correctly, providing market reflects its regular price of 3.16 per share. Given that Anixa Biosciences has information ratio of (0.07), we suggest you to validate Anixa Biosciences's prevailing market performance to make sure the company can sustain itself at a future point.

Anixa Biosciences Price Movement Analysis

Anixa Biosciences Insider Trading Activities

Anixa Biosciences Predictive Daily Indicators

Anixa Biosciences Corporate Filings

Anixa Biosciences Forecast Models

Anixa Biosciences' time-series forecasting models are one of many Anixa Biosciences' stock analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Anixa Biosciences' historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.

Stock analysis is the technique used by a trader or investor to examine and evaluate how Anixa Biosciences prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Anixa shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Stock such as Anixa Biosciences. By using and applying Anixa Stock analysis, traders can create a robust methodology for identifying Anixa entry and exit points for their positions.

We track the performance of the top 100 financial experts across various large and mid-size financial boutiques. Anixa analyst recommendations are determined by taking all analyst recommendations and averaging them as Strong Buy, Buy, Hold, Strong Sell or Sell. There is no one specific way to measure analysis performance other than comparing it to the past results via a very sophisticated attribution analysis. Anixa analyst consensus and target price projections should be used in combination with other traditional techniques such as stock price forecasting, technical analysis, earnings estimate, and various momentum models.

Anixa Biosciences stock analysis indicators help investors evaluate how Anixa Biosciences stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing and determine when trading Anixa Biosciences shares will generate the highest return on investment. By understating and applying Anixa Biosciences stock analysis, traders can identify Anixa Biosciences position entry and exit signals to maximize returns.

Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Anixa Biosciences. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in gross domestic product. For more information on how to buy Anixa Stock please use our How to Invest in Anixa Biosciences guide.You can also try the Transaction History module to view history of all your transactions and understand their impact on performance.

When running Anixa Biosciences' price analysis, check to measure Anixa Biosciences' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Anixa Biosciences is operating at the current time. Most of Anixa Biosciences' value examination focuses on studying past and present price action to predict the probability of Anixa Biosciences' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Anixa Biosciences' price. Additionally, you may evaluate how the addition of Anixa Biosciences to your portfolios can decrease your overall portfolio volatility.

Is Anixa Biosciences' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Anixa Biosciences. If investors know Anixa will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Anixa Biosciences listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.

The market value of Anixa Biosciences is measured differently than its book value, which is the value of Anixa that is recorded on the company's balance sheet. Investors also form their own opinion of Anixa Biosciences' value that differs from its market value or its book value, called intrinsic value, which is Anixa Biosciences' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Anixa Biosciences' market value can be influenced by many factors that don't directly affect Anixa Biosciences' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.

Please note, there is a significant difference between Anixa Biosciences' value and its price as these two are different measures arrived at by different means. Investors typically determine if Anixa Biosciences is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Anixa Biosciences' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.